J. Goldman & CO LP Esperion Therapeutics, Inc. Put Options Transaction History

J. Goldman & CO LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $1.03 Million - $1.72 Million	202,500 New	202,500 $1.26 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $2.47 Million - $6.65 Million	-90,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $194,700 - $329,010	5,500 Added 6.51%	90,000 $5.37 Million
Q2 2018 Aug 14, 2018	BUY	$36.2 - $76.4 $2.12 Million - $4.47 Million	58,500 Added 225.0%	84,500 $3.31 Million
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $217,350 - $337,150	-5,000 Reduced 16.13%	26,000 $1.71 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $1.36 Million - $1.64 Million	31,000	31,000 $1.55 Million

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $154M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.